Research ArticleArticle
Rheumatoid Arthritis Clinical Benefits from Abatacept, Cytokine Blockers, and Rituximab Are All Linked to Modulation of Memory B Cell Responses
Gregg J. Silverman and Adam Pelzek
The Journal of Rheumatology April 2014, jrheum.140022; DOI: https://doi.org/10.3899/jrheum.140022
Gregg J. Silverman
Gregg J. Silverman, MD; Departments of Medicine and Pathology; Adam Pelzek, MSc; Department of Pathology, New York University, New York, New York, USA. Address correspondence to Dr. G. Silverman, Department of Medicine, NYU School of Medicine, 450 E. 29th St., New York, New York 10016, USA. E-mail: Gregg.Silverman@nyumc.org
Adam Pelzek
Gregg J. Silverman, MD; Departments of Medicine and Pathology; Adam Pelzek, MSc; Department of Pathology, New York University, New York, New York, USA. Address correspondence to Dr. G. Silverman, Department of Medicine, NYU School of Medicine, 450 E. 29th St., New York, New York 10016, USA. E-mail: Gregg.Silverman@nyumc.org
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Rheumatoid Arthritis Clinical Benefits from Abatacept, Cytokine Blockers, and Rituximab Are All Linked to Modulation of Memory B Cell Responses
Gregg J. Silverman, Adam Pelzek
The Journal of Rheumatology Apr 2014, jrheum.140022; DOI: 10.3899/jrheum.140022